Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bezlotoxumab

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Abstract Background Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B indicated to prevent C… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2018
2018
Background Clostridium difficile infection (CDI) is the most commonly recognized cause of recurrent diarrhea. Bezlotoxumab… Expand
  • figure 2
Review
2018
Review
2018
Clostridium difficile infection (CDI) is the most common health care-acquired infection associated with high hospital… Expand
  • table 1
  • table 1
  • table 2
Highly Cited
2017
Highly Cited
2017
Background Clostridium difficile is the most common cause of infectious diarrhea in hospitalized patients. Recurrences are common… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Review
2017
Review
2017
During the past decade, the incidence and severity of Clostridium difficile infection (CDI) have significantly increased, leading… Expand
2017
2017
  • J. Bartlett
  • The New England journal of medicine
  • 2017
  • Corpus ID: 5337989
Clostridium difficile was identified in 1976 as the cause of “clindamycin colitis” in a study of the hamster model of the disease… Expand
2017
2017
The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible… Expand
Review
2016
Review
2016
Bezlotoxumab (Zinplava™) is a human monoclonal antibody against Clostridium difficile toxin B developed by Merck & Co. In October… Expand
Highly Cited
2014
Highly Cited
2014
Background: Bezlotoxumab is a neutralizing antibody targeting toxin B of Clostridium difficile. Results: The structure of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
Highly Cited
2014
Highly Cited
2014
ABSTRACT Clostridium difficile infection (CDI) represents the most prevalent cause of antibiotic-associated gastrointestinal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4